{"contract_version":"web-product-v1","provenance":{"source_url":"https://www.saglikaktuel.com/haber/fdadan-glp-1-grubu-ilaclar-icin-nadiri-gorme-kaybi-uyarisi-prospektuslere-naion-108950.htm","content_hash":"4f92ddb9af98d405a87fb0a3ac41956d96dc840a6565d1d252797df11f6ab5a2","story_version":1,"source_revision":null,"source_revision_status":"NOT_RECORDED_IN_PUBLIC_STORY_SCHEMA","publication_updated_at":"2026-11-10T13:45:21Z","published_at":"2026-11-10T16:28:00+03:00","hash_scope":"RECORDED_ARCHIVE_HASH_NOT_VERIFIED_ORIGINAL_BYTES"},"corrections":{"status":"PENDING_EVIDENCE","versions":[],"reason":"PUBLIC_CORRECTION_PUBLICATION_CONTRACT_REQUIRED"},"living_event":{"status":"PENDING_EVIDENCE","sources":[],"claims":[],"evidence":[],"counterevidence":[],"timeline":[],"uncertainty":[],"relations":[],"reason":"AUTHORIZED_PUBLIC_CHILD_PUBLICATION_CONTRACT_REQUIRED"},"analysis":{"contract_version":"web-product-v1","status":"PENDING_EVIDENCE","sections":[],"required_section_count":12,"section_slots":[{"section_id":1,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":2,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":3,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":4,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":5,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":6,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":7,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":8,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":9,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":10,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":11,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":12,"status":"MISSING_APPROVED_REPORT_DATA"}],"source_story":{"story_id":186039,"version":1,"content_hash":"4f92ddb9af98d405a87fb0a3ac41956d96dc840a6565d1d252797df11f6ab5a2"},"approved_heading_mapping":"PENDING_EVIDENCE","depth":null,"reason":"APPROVED_ANALYSIS_PUBLICATION_AND_HEADING_CONTRACT_REQUIRED"},"story":{"story_id":186039,"title":"FDA'dan GLP-1 Grubu İlaçlar İçin \"Nadiri Görme Kaybı\" Uyarısı: Prospektüslere NAION Riski Eklendi","summary":"ABD Gıda ve İlaç Dairesi (FDA), diyabet ve obezite tedavisinde kullanılan GLP-1 grubu ilaçların nadir görülen ancak kalıcı görme kaybına yol açabilen NAION riskini artırabileceğini belirterek prospektüslere uyarı eklenmesini zorunlu kıldı.","category":"saglik","country":"abd","published_at":"2026-11-10T16:28:00+03:00","source_url":"https://www.saglikaktuel.com/haber/fdadan-glp-1-grubu-ilaclar-icin-nadiri-gorme-kaybi-uyarisi-prospektuslere-naion-108950.htm","language":"tr","status":"PUBLISHED","version":1,"content_hash":"4f92ddb9af98d405a87fb0a3ac41956d96dc840a6565d1d252797df11f6ab5a2","subcategory":"","image_url":"https://www.saglikaktuel.com/d/news_t/19152.jpg","publication_updated_at":"2026-11-10T13:45:21Z","degree":"D3","source_language_status":"KNOWN","masa_classification_status":"RECORDED","spam_assessment_status":"RECORDED","source_language":"tr"},"entities":[],"related":[],"timeline":[],"evidence_visibility":"PENDING_PUBLICATION_CONTRACT","living_event_status":"PENDING_AUTHORIZED_API_CONTRACT"}